A meta-analysis suggests that the short-term benefits of bisphosphonate therapy likely outweigh the short-term harms for most older postmenopausal women who have osteoporosis. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Karen Rosenberg. Bisphosphonates Likely Beneficial for Most Older Women with Osteoporosis. The American journal of nursing. 2022 Apr 01;122(4):57
Mesh Tags
Substances
PMID: 35348523
View Full Text